Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

No significant differences were observed between the two groups regarding glycated serum protein or 25-hydroxyvitamin D3 levels see Figure 1.

Source: Comparative analysis between sarcopenic patients and sarcopenic patients with MetS. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Participants were categorized into three groups, including the non-sarcopenia group (n = 613), the sarcopenia group (n = 307) and the sarcopenia with MetS group (n = 50).

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association between estimated glucose disposal rate and metabolic syndrome in older adults with sarcopenia

Study design awaiting verification · Frontiers in Nutrition · 2026

Original publication title

Association between estimated glucose disposal rate and metabolic syndrome in older adults with sarcopenia

Min Zou; Hui Qin; Qing Xia; Jian Kang

Copyright © 2026 Zou, Qin, Xia and Kang.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In the older adult group, patients with sarcopenia have a higher possibility of developing metabolic syndrome (MetS) compared with those without sarcopenia. In addition to lower eGDR levels, frailty, elevated uric acid, BMI, and MDA levels are associate with a higher prevalence of MetS in individuals with sarcopenia. Machine learning-based regression models outperform univariate screening models in predicting MetS risk.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

Sarcopenia, an age-related syndrome marked by muscle mass and function decline, is closely linked to various adverse clinical outcomes. Insulin resistance (IR) has emerged as a pivotal link between sarcopenia and metabolic syndrome (MetS), significantly influencing their pathophysiological interactions. This study aimed to investigate the potential correlation between estimated glucose disposal rate (eGDR) and MetS among patients with sarcopenia, offering new insights into stratified prevention and treatment strategies.

Source: Objective

Abstract: What methods does the paper describe?

A total of 970 elderly individuals who visited the 921 Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army from January 2023 to December 2024 were enrolled. Participants were categorized into three groups, including the non-sarcopenia group (n = 613), the sarcopenia group (n = 307) and the sarcopenia with MetS group (n = 50). Key variables were selected using univariate screening, the support vector machine recursive feature elimination (SVM-RFE) algorithm, and the Boruta algorithm.

Three logistic regression models were constructed to evaluate the association between eGDR and MetS.

Source: Methods

Abstract: Result

The prevalence of MetS in elderly individuals with sarcopenia was 14.01% (50/357), significantly higher than that of those without sarcopenia (3.10%, 19/613), with an odds ratio (OR) of 5.09 (95% CI: 2.95 to 8.79). Among the 357 sarcopenia patients, the average eGDR level in the sarcopenia with MetS group was 9.60 (9.21, 10.03) mg/kg/min, which was lower than that in the sarcopenia group, 10.82 (10.55, 11.09) mg/kg/min (Z = 2.64, P < 0.01). The Boruta algorithm identified crucial variables for developing a logistic regression model, indicating an OR for eGDR of 0.54 (95% CI: 0.30 to 0.84).

The ORs for frailty and elevated cholesterol levels were 1.47 (95% CI: 1.01 to 2.94) and 3.94 (95% CI: 2.47 to 6.69), respectively. Model performance comparison showed that the Boruta and SVM-RFE-based models had higher area under the ROC curve values (0.78 and 0.75, respectively) than the univariate screening model (P < 0.05). Furthermore, subgroup analysis confirmed the robustness of the association between eGDR and MetS in elderly patients with sarcopenia.

Source: Result

Abstract: Conclusion

In the older adult group, patients with sarcopenia have a higher possibility of developing metabolic syndrome (MetS) compared with those without sarcopenia. In addition to lower eGDR levels, frailty, elevated uric acid, BMI, and MDA levels are associate with a higher prevalence of MetS in individuals with sarcopenia. Machine learning-based regression models outperform univariate screening models in predicting MetS risk.

Source: Conclusion
Authors’ abstract

Objective

Sarcopenia, an age-related syndrome marked by muscle mass and function decline, is closely linked to various adverse clinical outcomes. Insulin resistance (IR) has emerged as a pivotal link between sarcopenia and metabolic syndrome (MetS), significantly influencing their pathophysiological interactions. This study aimed to investigate the potential correlation between estimated glucose disposal rate (eGDR) and MetS among patients with sarcopenia, offering new insights into stratified prevention and treatment strategies.

Methods

A total of 970 elderly individuals who visited the 921 Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army from January 2023 to December 2024 were enrolled. Participants were categorized into three groups, including the non-sarcopenia group (n = 613), the sarcopenia group (n = 307) and the sarcopenia with MetS group (n = 50). Key variables were selected using univariate screening, the support vector machine recursive feature elimination (SVM-RFE) algorithm, and the Boruta algorithm.

Three logistic regression models were constructed to evaluate the association between eGDR and MetS.

Result

The prevalence of MetS in elderly individuals with sarcopenia was 14.01% (50/357), significantly higher than that of those without sarcopenia (3.10%, 19/613), with an odds ratio (OR) of 5.09 (95% CI: 2.95 to 8.79). Among the 357 sarcopenia patients, the average eGDR level in the sarcopenia with MetS group was 9.60 (9.21, 10.03) mg/kg/min, which was lower than that in the sarcopenia group, 10.82 (10.55, 11.09) mg/kg/min (Z = 2.64, P < 0.01). The Boruta algorithm identified crucial variables for developing a logistic regression model, indicating an OR for eGDR of 0.54 (95% CI: 0.30 to 0.84).

The ORs for frailty and elevated cholesterol levels were 1.47 (95% CI: 1.01 to 2.94) and 3.94 (95% CI: 2.47 to 6.69), respectively. Model performance comparison showed that the Boruta and SVM-RFE-based models had higher area under the ROC curve values (0.78 and 0.75, respectively) than the univariate screening model (P < 0.05). Furthermore, subgroup analysis confirmed the robustness of the association between eGDR and MetS in elderly patients with sarcopenia.

Conclusion

In the older adult group, patients with sarcopenia have a higher possibility of developing metabolic syndrome (MetS) compared with those without sarcopenia. In addition to lower eGDR levels, frailty, elevated uric acid, BMI, and MDA levels are associate with a higher prevalence of MetS in individuals with sarcopenia. Machine learning-based regression models outperform univariate screening models in predicting MetS risk.

Publication and source details

Original title: Association between estimated glucose disposal rate and metabolic syndrome in older adults with sarcopenia

Min Zou; Hui Qin; Qing Xia; Jian Kang

Frontiers in Nutrition · 2026

* Correspondence: Jian Kang, 2319716225@qq.comCopyright © 2026 Zou, Qin, Xia and Kang.2026Zou, Qin, Xia and Kanghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. Natural Science Foundation of Hunan Province (Grant No. 2025JJ81160).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:13:33.041842+00:00

DOI: 10.3389/fnut.2026.1795633 · PMC13357826